ViVerita Therapeutics Revenue

Biotechnology Research • Austria • 1-10 Employees

ViVerita Therapeutics revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding

Key Contact at ViVerita Therapeutics

Ulrich Elling

Chief Executive Officer

Company overview

Headquarters	Austria
Websites	viverita.at viveritatx.com
NAICS	541714
Employees	1-10
Socials

ViVerita Therapeutics Email Formats

ViVerita Therapeutics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@viveritatx.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@viveritatx.com	100%

About ViVerita Therapeutics

Viverita Therapeutics uses proprietary platforms to identify and validate therapeutic targets in the physiologic context to empower first in class precision oncology.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

ViVerita Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

ViVerita Therapeutics has never raised funding before.

ViVerita Therapeutics Tech Stack

Discover the technologies and tools that power ViVerita Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Lodash

JavaScript libraries

Sentry

Issue trackers

Sirvoy

Appointment scheduling

GoDaddy

Hosting

Wix

Blogs

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

React

JavaScript frameworks

Google Cloud

IaaS

Google Cloud CDN

CDN

Envoy

Reverse proxies

Frequently asked questions

ViVerita Therapeutics is located in AT.

ViVerita Therapeutics generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

ViVerita Therapeutics has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

ViVerita Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at ViVerita Therapeutics

Ulrich Elling

Chief Executive Officer

4.8

40,000 users